University of Dundee

Drug Discovery Unit

Short Code: 
DDU

Dundee researchers target protein to tackle COVID-19

University of Dundee researchers are studying a protein that aids the spread of COVID-19 in the hope of finding ways of blocking its function.

The team, from the University’s Medical Research Council Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU) are working in partnership with the Drug Discovery Unit (DDU) to study an enzyme found within the SARS-CoV-2 virus that causes COVID-19 infection.

Dundee expertise aids COVID-19 testing effort

The University of Dundee has helped establish Scotland’s central COVID-19 testing facility in support of the national response to the coronavirus pandemic.

The centre, based at the University of Glasgow, was announced by the UK Government yesterday as part of a series of measures to increase testing and response to the spread of COVID-19 across the UK. It will be opened in collaboration with the Scottish Government and industry experts from BioAscent Discovery Ltd and Dundee’s Drug Discovery Unit (DDU).

RSE honour for Life Sciences academics

Two Life Sciences academics who are helping transform lives with their work on major diseases including Parkinson’s and neglected tropical diseases such as malaria have been elected Fellows of the Royal Society of Edinburgh (RSE).

The RSE is Scotland’s national academy, focused on delivering its mission of `knowledge made useful’. Fellows are elected in recognition of their impact in improving the world around them.

Dundee joins ERA4TB international project fighting tuberculosis

The University of Dundee is among more than 30 international institutions joining forces to find new drug treatments for tuberculosis.

The ERA4TB (European Regimen Accelerator for Tuberculosis) project is a public-private initiative dedicated to the development of drugs against tuberculosis. With a team of more than 30 organisations and a budget of over 200 million euros, ERA4TB will focus on developing a new, improved tuberculosis treatment. The partners will share their expertise, knowledge and resources to rapidly progress new candidate drugs into clinical trials.

School Prizes presented at Review of the Year 2019

Review of the Year 2019 took place today with the Dean, Julian Blow sharing the highlights of activity within the School from 2019. The presentation closed with the annual School prizes presentation. Here are the winners:

Innovator of the Year

Innovator of the Year is for any member or team within SLS that demonstrably achieved scientific, technical or commercial innovation that came to fruition in 2019.

Pages